BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $40
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $30 to $40.
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $30 to $40.
